Harmony Biosciences Holdings (HRMY) Share-based Compensation (IS) (2024 - 2026)
Harmony Biosciences Holdings (HRMY) recorded Share-based Compensation (IS) of $9.58 million in Q2 2026, down 16.0% from $11.39 million a year earlier and down 7.1% from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
On a TTM basis, Harmony Biosciences Holdings' Share-based Compensation (IS) came in at $41 million as of Jun 30, 2026, down 9.2% year-over-year; for FY2025, it came in at $44.96 million, up 5.3% from FY2024.
- Annual Share-based Compensation (IS) has increased for three straight years, with a three-year compound annual growth rate of 18.7% (FY2022 to FY2025).
- Across earlier years, Share-based Compensation (IS) came in at $42.7 million in FY2024 (+36.8%), $31.21 million in FY2023 (+16.0%) and $26.91 million in FY2022.
- The Q2 2026 figure is the lowest quarterly Share-based Compensation (IS) in data going back to Q1 2024.
- On a year-over-year basis, Share-based Compensation (IS) rose in three of the last six quarters, with an average decline of 1.8%.
- Per Business Quant, the preceding three quarters came in at $10.31 million (Q1 2026), $10.29 million (Q4 2025) and $10.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -474.81 Mn | 198.08 Mn | 9.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.58 Mn |
| Mar 31, 2026 | 10.31 Mn |
| Dec 31, 2025 | 10.29 Mn |
| Sep 30, 2025 | 10.82 Mn |
| Jun 30, 2025 | 11.39 Mn |
| Mar 31, 2025 | 12.45 Mn |
| Dec 31, 2024 | 9.86 Mn |
| Sep 30, 2024 | 11.45 Mn |
| Jun 30, 2024 | 10.96 Mn |
| Mar 31, 2024 | 10.43 Mn |
API Access
Harmony Biosciences Holdings Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();